Skip To Main Content
M Yang on Muck Rack

M Yang

As seen in: Scientia Iranica, Value in Health Journal
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to M Yang’s profile

Articles by M Yang

|
By M Yang, EC Tan, Y Chen
| secure.jbs.elsevierhealth.com
Open in Who Shared Issue with article?
|
By M Yang, C Liao, EC Tan
| secure.jbs.elsevierhealth.com
Open in Who Shared Issue with article?
|
By J Gambari, M Yang, CA Chowdhury, S Duttagupta
| secure.jbs.elsevierhealth.com
Open in Who Shared Issue with article?
|
By J Gambari, CA Chowdhury, S Duttagupta, M Yang
| secure.jbs.elsevierhealth.com
Open in Who Shared Issue with article?
|
By C Huang, M Yang
| secure.jbs.elsevierhealth.com
Open in Who Shared Issue with article?
|
By J Zhou, M Yang
| secure.jbs.elsevierhealth.com
Open in Who Shared Issue with article?

Indirect Comparison Of Efficacy Of PonatiniB Versus Bosutinib In 3rd-Line Chronic-Phase Chronic Myeloid Leukemia Using Iterative Proportional Fitting

|
By Lj McGarry, M Yang, S Chiroli, S Lustgarten, D Dorer
| Value in Health Journal Verified
Open-label uncontrolled trials of ponatinib (PACE) and bosutinib (NCT00261846; published by Khoury 2012) in CP-CML suggest ponatinib is more efficacious than bosutinib in third-line patients. However, lack of head-to-head randomized trials comparing third-line treatments poses a challenge for clinical and reimbursement decisions.
Open in Who Shared Issue with article?
Show More